Pierre Fabre Laboratories gets green light from EC for BRAFTOVI® (encorafenib) and MEKTOVI® (binimetinib) combo to treat adults with advanced BRAFV600E-mutant NSCLC.
Sep 4th latest updates in the global new drug development field, including progress in new drug research and development, transaction information, and partnership developments.
Patsnap Bio, with its chemical modification search function, provides users with a powerful tool for exploring multidimensional nucleotide sequence information.
at the ESC Congress, Bayer published the pooled analysis of the Phase III FINE-HEART study on finerenone, along with the latest data from the FINEARTS-HF trial.
Sep 3rd latest updates in the global new drug development field, including progress in new drug research and development, transaction information, and partnership developments.